VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

AACR 2022 | Unanswered questions in DCIS progression

Tanjina Kader, PhD, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses a recent breakthrough in ductal carcinoma in situ (DCIS) implicating myoepithelial invasion as a prognostic marker for DCIS progression to invasive cancer. More research needs to be carried out to characterize this process, with a focus on the role of cellular communication with surrounding stromal and immune cells. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter